CD22-targeted CAR-T immunotherapy  >>  Stanford University  >>  Phase 2
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials		 012345678910
            
            
             
firicabtagene autoleucel (CRG-022) / CARGO Therap